市场调查报告书
商品编码
1518770
全球数位糖尿病管理市场 2024-2031Global Digital Diabetes Management Market 2024-2031 |
数位糖尿病管理市场规模、份额和趋势分析报告,按产品和服务(设备、应用程式、数据管理软体和平台以及服务)、设备类型(可穿戴设备和手持设备)以及最终用户(医院和家庭环境)预测期(2024-2031)
预计数位糖尿病管理市场在预测期内(2024-2031)将以 14.6% 的复合年增长率成长。数位糖尿病管理是指使用基于技术的工具和应用程式来帮助个人管理糖尿病。这些数位解决方案可以包括行动应用程式、线上平台和连接设备,用于追踪和分析血糖水平、饮食、运动和药物依从性等健康资料。对糖尿病及时管理以限制其对健康影响的需求日益增长,这是这一全球市场成长的主要动力。
Digital Diabetes Management Market Size, Share & Trends Analysis Report by Products & Services (Devices, Applications, Data Management Software & Platforms, and Services), by Device Type (Wearable Devices, and Hand-Held Devices), and by End-User (Hospitals, and Home Settings) Forecast Period (2024-2031)
Digital diabetes management market is anticipated to grow at a CAGR of 14.6% during the forecast period (2024-2031). Digital diabetes management refers to the use of technology-based tools and applications to aid individuals in managing their diabetes. These digital solutions can include mobile apps, online platforms, and connected devices that track and analyze health data such as blood glucose levels, diet, exercise, and medication adherence. The growing need for the on-time management of diabetes to limit its impact on health is a major motivator for the growth of this global market.
Market Dynamics
Advancements in Digital Health Technology
The ongoing advancements in digital health technology, such as continuous glucose monitoring (CGM) systems, smart insulin pens, and advanced data analytics, are propelling the market forward. CGMs can alert users when the glucose levels are rising or dropping, and how quickly. This can help users to decide how to reach their target range. For instance, if your blood sugar is 110 and an arrow is pointing down, it could mean that your blood sugar could drop to 60-90 points in 30 minutes, which might not be safe. Advancements in digital diabetes management products and services allow users to make informed decisions, which leads to fewer emergencies.
Rising Focus on Personalized Healthcare
Personalized healthcare in digital diabetes management is a patient-centered approach that tailors treatment and management strategies to individual patient needs and preferences. Digital Twins and Personal Health Knowledge Graphs (PHKGs), Continuous Glucose Monitoring (CGM), Virtual Care and Telehealth, Mobile Health Apps, and Artificial Intelligence (AI). These innovative concepts involve creating a digital replica of a patient's health profile and integrating data from diverse sources to provide real-time, patient-centric care. Personalized virtual care using telehealth services, including CGM, can improve glycemic control and reduce diabetes-related distress.
Market segmentation
Hospitals Lead the Way in the Digital Diabetes Management Market
Hospitals play a crucial role in digital diabetes management by integrating advanced technologies into their care protocols to provide better outcomes for patients with diabetes. Hospitals are increasingly integrating patient data from various digital sources into their Electronic Health Records (EHR) systems for a more comprehensive view of a patient's health status. Additionally, hospitals are at the forefront of research into new digital diabetes management technologies, often conducting clinical trials to test the efficacy and safety of new devices and apps.
The global digital diabetes management market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America holds largest market share
The advanced healthcare regional infrastructure is conducive to the adoption of new technologies. Robust research and development infrastructure along with growing funding for diabetes research is further aiding the regional market share. The significant presence of the diabetic population along with new product launches to meet user's demands is further driving the regional market growth. For instance, in October 2023, Insulet received 510(k) clearance from the Food and Drug Administration for its Omnipod 5 application on iPhone, which allows people to control their insulin pump from a smartphone. Insulet included an Android app when it first launched its Omni pod 5 pump last year. The iPhone app has the same functions with a few new features.
The major companies serving in the global digital diabetes management market include Abbott Laboratories, B. Braun Melsungen AG, Medtronic Plc, DarioHealth Corp., and Sanofi SA among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market.